Our findings strongly demonstrate that siglec-E plays an adaptative role in protecting the adipocytes from inflammatory-mediated injury through reduced immune cell recruitment and TRAF3/Akt2 activity in AT during the early phase of obesity progression. The gene discussed is TRAF3; the disease is obesity disorder.